Rune Labs, a leader in precision medicine for Parkinson’s Disease (PD), has launched StrivePD Guardian, a personalized care service that combines expert coaching with AI-powered symptom and risk analysis to provide continuous support for patients and caregivers. With a shortage of movement disorder specialists in the U.S., many individuals with Parkinson’s struggle to receive guidance between doctor visits.
StrivePD Guardian bridges critical care gaps by integrating real-time personalized coaching, AI-powered health monitoring, and proactive insights. Built on Rune Labs’ value-based care framework validated in 2024, the program has demonstrated significant benefits, including nearly a 50% reduction in emergency room visits, an 18% reduction in specialists’ time, a 90% increase in patient exercise engagement, and an 80% improvement in medication adherence.
As a subscription-based service, StrivePD Guardian combines human support with advanced Large Language Model (LLM) technology, leveraging patient data from StrivePD and FDA-cleared Apple Watch monitoring. This enhances yearly clinical visits by optimizing treatment strategies and enabling on-demand, data-informed care. Users are paired with dedicated coaches who provide guidance, monitor progress, and support care management while tracking FDA-cleared measures such as tremor and dyskinesia. AI-driven analysis translates patient data into actionable insights, assisting clinicians and patients in making informed decisions about exercise, therapies, symptom management, and clinical trial participation. Continuous health monitoring detects potential high-risk events, such as falls or complications, with timely alerts to prevent escalation. Additionally, the platform connects families, ensuring they remain informed and reassured about their loved one’s care.
StrivePD Guardian empowers patients by enhancing symptom stability and improving disease management. Users report greater control over movements, more consistent exercise routines, and better adherence to medications. By leveraging over 4.5 million patient-days of data, StrivePD’s predictive modeling and AI-driven insights continuously refine and personalize Parkinson’s care, supporting both patients and healthcare providers in achieving better outcomes.
Click here to read the original news story.